A Panel of CA19-9, Ca125, and Ca15-3 as the Enhanced Test for the Differential Diagnosis of the Pancreatic Lesion

Table 7

	Sensitivity	Specificity	Proper diagnosis of resectable PDAC ()	Proper diagnosis of resectable benign lesion ()
CA19-9	58,97%	79,35%	36/66 (54,54%)	48/53 (90,56%)
Model	81,2%	63,1%	46/66 (69,7%)	41/53 (77,36%)
	Δ = 22,23%	Δ = −16,25%	Δ = 15,16%	Δ = −13,2%